Free Trial
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$2.28 -0.30 (-11.63%)
Closing price 10/7/2025 04:00 PM Eastern
Extended Trading
$2.33 +0.05 (+1.97%)
As of 10/7/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardlytics Stock (NASDAQ:CDLX)

Advanced

Key Stats

Today's Range
$2.27
$2.67
50-Day Range
$0.89
$2.82
52-Week Range
$0.85
$5.24
Volume
2.63 million shs
Average Volume
13.49 million shs
Market Capitalization
$121.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.25
Consensus Rating
Hold

Company Overview

Cardlytics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 56% of companies evaluated by MarketBeat, and ranked 146th out of 320 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Cardlytics is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardlytics has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Cardlytics' valuation and earnings.
  • Percentage of Shares Shorted

    12.02% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 15.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.02% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 15.79%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cardlytics has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Cardlytics this week, compared to 5 articles on an average week.
  • Search Interest

    42 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 4,100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Cardlytics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $204,204.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDLX Stock News Headlines

Craig-Hallum Keeps Their Hold Rating on Cardlytics (CDLX)
URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.tc pixel
Cardlytics Announces Major Workforce Reduction Plan
Cardlytics: Debt Overhang Casts Shadow On Upside
Cardlytics reduces workforce by 30%
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $3.71 at the beginning of 2025. Since then, CDLX shares have decreased by 38.5% and is now trading at $2.28.

Cardlytics, Inc. (NASDAQ:CDLX) posted its quarterly earnings data on Wednesday, November, 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. The business's revenue for the quarter was down 15.1% compared to the same quarter last year.
Read the conference call transcript
.

Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
11/06/2024
Today
10/07/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
CIK
1666071
Fax
N/A
Employees
500
Year Founded
2008

Price Target and Rating

High Price Target
$2.50
Low Price Target
$2.00
Potential Upside/Downside
-1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$189.30 million
Net Margins
-68.87%
Pretax Margin
-68.87%
Return on Equity
-279.39%
Return on Assets
-48.17%

Debt

Debt-to-Equity Ratio
2.87
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$278.30 million
Price / Sales
0.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
1.65

Miscellaneous

Outstanding Shares
53,240,000
Free Float
50,895,000
Market Cap
$121.39 million
Optionable
Optionable
Beta
1.45

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners